Background {#Sec1}
==========

Excessive seasonal temperatures predispose to adverse heat-related human morbidity in multiple organ systems \[[@CR1], [@CR2]\]. These health effects have mostly been investigated with regards to cardiovascular, respiratory and well-known heat-related diseases \[[@CR3]\], but have also been observed for renal disease \[[@CR1], [@CR3]--[@CR6]\]. This is becoming increasingly more relevant due to the impact of climate change \[[@CR7]--[@CR9]\]. Two studies in Adelaide, Australia, showed increased admissions for renal disease during heatwaves through all ages, by 10% and 13%, respectively \[[@CR10], [@CR11]\], and another study in Adelaide also identified an association between temperature and renal disease \[[@CR12]\]. International studies have shown similar results \[[@CR3], [@CR13]--[@CR15]\]. Studies in the United States of America (USA) linked incremental rises in same-day apparent temperatures to an increased occurrence of renal disease and acute kidney injury (AKI, also known as acute renal failure) \[[@CR1], [@CR13]\].

In many cities, high temperatures have been linked to an increased occurrence of AKI \[[@CR3], [@CR11], [@CR13], [@CR15]--[@CR17]\] and chronic kidney disease (CKD, also known as chronic renal failure) \[[@CR18], [@CR19]\]. A study in Sydney, Australia, reported that the incidence of AKI and renal failure (AKI and CKD combined) increased if the daily temperature was above the 95th percentile range for one day, and this further increased if the high temperature persisted for three days \[[@CR4]\]. AKI and urolithiasis also predispose to chronic kidney disease, though paradoxically, CKD can help prevent urolithiasis due to a disease-associated decrease in urinary calcium secretion \[[@CR20], [@CR21]\].

The risk of renal colic (pain due to urolithiasis) increases with higher daily temperature \[[@CR22]--[@CR26]\]. Studies in Australia and New Zealand have demonstrated seasonal variation in the incidence of renal colic, highest in summer and autumn \[[@CR8], [@CR27], [@CR28]\]. A USA study also reported that the incidence of urolithiasis is greatest in warmer areas, specifically uric acid and calcium stones \[[@CR14]\]. Even though urinary stones usually form over months \[[@CR25], [@CR29]\], investigations in Sydney and the USA showed the risk for urolithiasis was highest ≤3 days after exposure to high ambient temperatures, with a peak at day one \[[@CR4], [@CR13], [@CR30]\]. The risk can be increased for the next 20 days as well \[[@CR25]\]. It has been suggested that the incidence and prevalence of urolithiasis are increasing due to climate change \[[@CR14], [@CR31]\].

Research on the relationship between ambient air temperature and urinary tract infections (UTIs) is inconclusive. UTIs include pyelonephritis (infection of renal pelvis, calyces and/or tissue) and lower urinary tract infections (LUTIs) which are UTIs occurring below the renal pelvis. One trial in the USA found a positive association between hospitalizations during heatwaves and primary diagnoses for UTIs and septicemia \[[@CR3]\]. Other studies have not found such association \[[@CR4]\]. Hospitalizations and ED admissions for nephritis increased significantly during the 2006 California heatwave \[[@CR17]\].

Whilst studies in different countries have examined these various renal outcomes, their results might not be generalizable to countries with different climate and population characteristics \[[@CR32], [@CR33]\]. A previous study in Adelaide, Australia, found increased incidence of AKI and renal disease during heatwaves \[[@CR11]\]. The present study extends those findings by considering a wider range of specific renal diseases and their associations with temperature. It is the first study to investigate the link between heat exposure and urolithiasis, UTIs and CKD in an Australian population. The results will have clinical and public health implications for the management of renal diseases in a temperate climate region.

Methods {#Sec2}
=======

Aim and design {#Sec3}
--------------

To examine if the incidence of eight temperature-prone specific renal disease categories in metropolitan Adelaide would increase in relation to a 1°C increase in daily dry bulb temperature. This study is an ecological study with a time-series approach.

Setting {#Sec4}
-------

Adelaide's predicted population in June 2016 was 1.32 million \[[@CR34]\]. With a total land area of 983,482 km^2^ \[[@CR35]\], the state has a semi-arid climate with mild winters and dry, hot summers with cool nights \[[@CR36]\]. Adelaide recently experienced multiple heatwaves including during March 2008, January to February 2009, November 2009 and during the summer of 2013--2014 \[[@CR37]\]. 2013 was the warmest year on record for Adelaide, and 2015 was the second warmest \[[@CR38]\]. Increased frequency, intensity and duration of hot days are predicted in Australia with climate change \[[@CR39]\].

Data collection {#Sec5}
---------------

Hospital inpatient and ED admissions data for a range of International Classification of Diseases, 10th revision (ICD-10) classification codes were acquired from the South Australian Department of Health for the period spanning 1 July 2003 to 31 March 2014. Data represented admissions to hospitals within the Adelaide metropolitan region. Elective admissions (patient did not require admission within 24 h) were excluded from the data because emergency admissions (patient required admission within 24 h) are more likely to reflect the acute effects of heat exposure.

Daily meteorological data for maximum and minimum dry bulb temperature were obtained from the Bureau of Meteorology from a monitoring station in Kent Town (station number 023090) \[[@CR37]\], Adelaide. Data from this station is representative of climate across the Adelaide metropolitan area. Because this data only represented the metropolitan area, admission of patients living in rural areas were excluded from this study. Daily maximum and minimum temperatures were recorded at 9 am; the data is included in Additional file [1](#MOESM1){ref-type="media"}. The highest temperature recorded in the 24 h prior to 9 am is recorded as the maximum daily temperature for the previous day which usually occurs in the afternoon, while the lowest temperature occurring in the same 24 h is recorded as the daily minimum temperature for the current day which usually occurs overnight or near dawn \[[@CR40]\]. The average daily temperature was calculated from these daily maximum and minimum temperatures. Descriptive statistics of the temperature data is included in Table [1](#Tab1){ref-type="table"}.Table 1Descriptive statistics for temperatureTemperatureMeanSD5th percentile95th percentileMedianMaximum27.46.2618.238.726.7Minimum15.544.488.823.715Average21.474.9414.130.8520.85Descriptive statistics for daily dry bulb maximum, minimum and average temperature in Adelaide from 1 July 2003 to 31 March 2014 excluding the warm season (October -- March)

Diseases were classified according to the ICD-10 codes. Admissions data were accessed for records with a primary diagnosis of renal disease (N00 -- N39). Primary diagnoses were obtained for both inpatient and ED admissions, and also up to two secondary diagnoses were obtained for inpatient admissions. Secondary diagnoses could not be obtained for ED admissions due to South Australian (SA) Department of Health protocol. Admissions were then further classified on specific primary and/or secondary diagnoses for eight renal diseases. These diseases were urolithiasis (N20 -- N23), renal failure (N17 -- N19.9), AKI (N17.0--17.9), CKD (N18.1 -- N18.9), UTIs (N10 -- N12, N30, and N39.0--39.2), LUTIs (N30; N39.0 -- N39.2), and pyelonephritis (N10 -- N12). UTIs were investigated (i) collectively (pyelonephritis and LUTIs) to enable comparison with previous studies that did not sub-classify UTI based on the site of infection \[[@CR3], [@CR41]\] and (ii) separately to provide more detailed information. Similarly, both AKI and CKD were investigated both separately and collectively, as renal failure, for comparison with previous studies that grouped AKI and CKD together \[[@CR30]\].

Data analyses {#Sec6}
-------------

Negative binomial (NB) regression models were used to estimate incidence rate ratios (IRRs) for daily admissions for various renal diseases (outcome variables) per 1°C increase in maximum, minimum and average temperature. Negative binomial models were deemed appropriate because of the overdispersion in the data. The models were adjusted for the effects of year, month, day of the week and holidays by including categorical variables for each covariate, and the outcomes were aggregated by day. Separate regression models were generated for inpatient and ED admissions. Models were time-stratified including only admissions occurring within the warm season (October to March), because the focus of the study was heat-related renal morbidity; including the cold season could introduce the confounding effect of cold on renal disease incidence \[[@CR11], [@CR12], [@CR42], [@CR43]\]. Years were assigned from 1 July to 30 June (financial years) to ensure continuity across successive warm seasons. Secondary analyses were performed to (i) examine renal admissions following a lag period of 1--5 days after daily temperatures, (i) repeat the primary analysis with further stratification by gender, and (iii) repeated the primary analysis with stratification by age instead of gender (\<65 years and ≥65 years old). All statistical analyses were conducted using Stata v13.0 (Statacorp, Texas, USA) with a significance level of *P* \< 0.05.

NB models were used because the outcome variables were counts, and these models are appropriate for overdispersed data. Goodness-of-fit tests were undertaken to indicate if Poisson models, the standard model of choice for count variables, fit the data \[[@CR44]\]. These tests indicated a poor fit, as shown in Appendix [1](#Sec11){ref-type="sec"}. As the data contains very few zero values, the poor fit was likely secondary to overdispersion, justifying the use of NB models.

The primary statistical models can be represented by the equation:$$\documentclass[12pt]{minimal}
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*N* designates the expected number of admissions for the specified renal disease *renal*. *Temp* is a variable representing daily temperature across all the days included in the study, specified as either maximum, minimum or average temperature. *β* ~*1*~ is the regression coefficient representing the effect of a 1°C increase in *temp*. Exp(*β* ~*1*~) is the calculated IRR for an increase in admissions per 1°C increase in temperature. In short, *β* ~*1*~ *temp* represents the effect of temperature. Similarly *β* ~*2*~ *holiday* represents the effect of whether the day was a public holiday. *β* ~*3 + m*~ *month* ~*m*~ represents the effect of the month; using a categorical variable for each month (*m*) from October to March. Similarly, *β* ~*9 + n*~ *day* ~*n*~ represents the effect of the day of the week, using a categorical variable for each day of the week (*n*). *β* ~*16 + o*~ *year* ~*o*~ represents the effect of the year, using a categorical variable for each financial year (o) within this study. *β* ~*0*~ and *u* ~*t*~ represent estimated constants in the model; u~t~ is specifically included in NB models to account for extra variance.

Results {#Sec7}
=======

A total of 3927 days were included in the study period, with a total of 83,519 ED and 42,957 inpatient admissions for renal disease. Table [2](#Tab2){ref-type="table"} provides summary statistics for daily incidence of inpatient and ED admissions for specific renal diseases, showing positively skewed distributions for renal admissions. Mean daily admissions for renal diseases during the warm season were 11.5 for inpatient and 22.4 for ED admissions.Table 2Summary statistics for admissions for renal diseaseDescriptionObservational time period (days)Daily incidence of admissionsTotal admissionsEDInpatientEDInpatientMeanSDMin MaxMeanSDMin MaxTotal renalTotal: 392721.276.0454610.944.2513283,51942,957diseaseCold season: 192220.265.5354210.323.9012838,93119,834Warm season: 200522.246.3584611.534.4813244,58823,123UrolithiasisTotal: 39274.882.520182.091.5401019,1718206Cold season: 19224.382.230151.861.440984093578Warm season: 20055.372.690182.311.6001010,7624628Renal failureTotal: 39271.791.530131.841.5301370247213Cold season: 19221.701.46071.751.470832633359Warm season: 20051.881.580131.921.5801337613854AKITotal: 39271.081.190101.401.3401242535483Cold season: 19220.991.08061.291.240719042481Warm season: 20051.171.270101.501.4201223493002CKDTotal: 39270.500.73050.860.990619593390Cold season: 19220.510.75050.850.99059761634Warm season: 20050.490.70040.880.98069831756UTITotal: 392713.704.392336.362.9201953,78924,985Cold season: 192213.304.192316.122.7501925,55911,754Warm season: 200514.084.552336.603.0501928,23013,231Lower UTITotal: 392712.273.971315.352.6401548,20320,997Cold season: 192211.973.801265.192.4901423,0049978Warm season: 200512.574.112315.502.7601525,19911,019PyelonephritisTotal: 39271.421.34091.211.130755864755Cold season: 19221.331.29091.101.070625552123Warm season: 20051.511.38091.311.170730312632Summary statistics for daily admission rates and total admissions for renal diseases in Adelaide from 1 July 2003 to 31 March 2014. Admissions are divided into cold season (April -- September) and warm season (October -- March). Both emergency department (ED) and inpatient admissions are included. Accompanying the mean daily admission rate (mean) are the standard deviation (SD) and the minimum (min) and maximum (max) number of daily admissions

Figure [1](#Fig1){ref-type="fig"} shows the incidence of mean daily admissions for all renal disease and urolithiasis plotted against year, month and day of the week. Admissions were highest during the warmest months (December -- March) and from Monday to Friday. Mean daily admissions for renal failure, AKI, CKD, UTIs, LUTIs and pyelonephritis showed similar trends in relation to time (data not shown). Mean daily admissions for renal diseases were plotted against daily maximum temperature rounded to the nearest degree for ED and inpatient admissions (Fig. [2](#Fig2){ref-type="fig"} and Fig. [3](#Fig3){ref-type="fig"} respectively). The relationships between admissions and temperature appeared linear and positive as evidenced by the line of best fit. Stronger relationships with temperature were apparent for total renal disease (a), urolithiasis (b), renal failure (c) and AKI (d), with weaker relationships apparent for the other renal categories. The results between ED and inpatient admissions were similar apart from a greater percentage of increase in UTI and LUTI inpatient admissions compared to ED admissions. At very high temperatures (starting at approximately 40°C), there were fewer observations for daily admission counts; this showed as greater scattering and the presence of outliers. These outliers are likely to have had minimal impact on estimating the effect of temperature because they only represented a very small number of days.Fig. 1Mean daily renal admissions by year, month and day. Mean daily admissions for total renal disease and urolithiasis plotted against year, month and day of the week in Adelaide. Both inpatient and emergency department (ED) admissions were included. Holidays were excluded from the data. The time period illustrated in the dot graphs examining month and day of the week was 1 July 2003--31 March 2014 Fig. 2Daily maximum temperature and mean hospital emergency department renal admissions. Descriptive graphs for mean number of daily hospital emergency department admissions for renal disease in relation to daily maximum temperature, during the warm season (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Data points are separated by 1°. Graphs are in relation to (**a**) total renal disease; (**b**) urolithiasis; (**c**) renal failure; (**d**) AKI; (**e**) CKD; (**f**) UTI; (**g**); lower UTI; (**h**) pyelonephritis Fig. 3Daily maximum temperature and mean hospital inpatient renal admissions. Descriptive graphs for mean number of daily hospital inpatient admissions for renal disease in relation to daily maximum temperature rounded to the nearest 1°C during the warm season (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Data points are separated by 1°. Graphs are in relation to (**a**); total renal disease (**b**); urolithiasis (**c**); renal failure (**d**); AKI (**e**); CKD (**f**); UTI (**g**); lower UTI (**h**); pyelonephritis

Table [3](#Tab3){ref-type="table"} shows estimated IRRs for each renal disease outcome in relation to a 1°C increase in daily maximum, minimum and average temperature for inpatient and ED admissions. A positive relationship was identified for total renal disease, urolithiasis, renal failure and AKI for both inpatient and ED admissions, as well as for UTI and LUTI for inpatient admissions. Minimum temperature (but not maximum and average temperature) was also associated with statistically significant increase for ED admissions for CKD, UTI and LUTI. Minimum temperature appeared to be associated with the greatest increase followed by average temperature. The highest effect was apparent for admissions for AKI. There was a 3.7% increase in ED admissions for AKI for each 1°C increase in minimum temperature (IRR = 1.037, 95% CI 1.026--1.048 *P* \< 0.001). A comparable effect was also observed for renal failure for both ED and inpatient admissions in association with 1°C increases in average and minimum temperature, with the other outcomes either showing a smaller increase or no significant effect. Pyelonephritis admissions showed no association with any of the temperature metrics. These results are also shown graphically in Fig. [4](#Fig4){ref-type="fig"}.Table 3Regression analysis for temperatureTemperature dataAdmission dataDiseaseIRR95% CI*P*-valueMaximumEDAll renal disease1.0041.002--1.005\<0.001Urolithiasis1.0061.003--1.010\<0.001Renal failure1.0181.012--1.024\<0.001AKI1.0231.016--1.031\<0.001CKD1.0050.994--1.0160.365UTI1.0010.999--1.0030.411Lower UTI1.0010.999--1.0030.507Pyelonephritis1.0020.995--1.0090.547InpatientAll renal disease1.0061.004--1.009\<0.001Urolithiasis1.0071.002--1.0120.009Renal failure1.0161.010--1.022\<0.001AKI1.0201.013--1.026\<0.001CKD1.0060.997--1.0140.171UTI1.0041.001--1.0080.005Lower UTI1.0051.002--1.0090.002Pyelonephritis1.0020.996--1.0090.472MinimumEDAll renal disease1.0091.006--1.011\<0.001Urolithiasis1.0151.010--1.020\<0.001Renal failure1.0301.022--1.039\<0.001AKI1.0371.026--1.048\<0.001CKD1.0171.001--1.0330.036UTI1.0041.000--1.0070.023Lower UTI1.0031.000--1.0060.045Pyelonephritis1.0060.996--1.0150.245InpatientAll renal disease1.0121.008--1.015\<0.001Urolithiasis1.0141.007--1.022\<0.001Renal failure1.0241.015--1.032\<0.001AKI1.0281.019--1.038\<0.001CKD1.0110.999--1.0230.068UTI1.0081.003--1.012\<0.001Lower UTI1.0091.004--1.014\<0.001Pyelonephritis1.0050.995--1.0140.346AverageEDAll renal disease1.0071.004--1.009\<0.001Urolithiasis1.0121.007--1.016\<0.001Renal failure1.0281.020--1.036\<0.001AKI1.0351.025--1.045\<0.001CKD1.0110.997--1.0260.125UTI1.0020.999--1.0050.121Lower UTI1.0020.999--1.0050.184Pyelonephritis1.0040.995--1.0130.364InpatientAll renal disease1.0101.007--1.013\<0.001Urolithiasis1.0121.005--1.0190.001Renal failure1.0231.016--1.031\<0.001AKI1.0291.020--1.037\<0.001CKD1.0100.999--1.0210.087UTI1.0071.003--1.0110.001Lower UTI1.0081.004--1.013\<0.001Pyelonephritis1.0040.995--1.0130.378Estimated incidence rate ratios (IRRs) and associated 95% confidence intervals and *P*-values for daily admissions for renal diseases in relation to an increase in daily temperature (maximum, minimum and average) per 1°C during the warm seasons (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Both emergency department (ED) and inpatient admissions were included Fig. 4Estimated incidence rate ratios (IRRs) for renal outcomes and daily temperature. Graphs for incidence rate ratios (IRRs) for daily admissions for renal diseases and associated 95% confidence intervals (95% CI) in relation to daily temperature per 1°C, during the warm season (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Both emergency department (ED) and inpatient (IP) admissions are included. Graphs are in relation to (**a**); maximum temperature (**b**); minimum temperature (**c**); average temperature. The renal categories represented are total renal disease (Total), urolithiasis (Uro), renal failure (RF), acute kidney injury (AKI), chronic kidney disease (CKD), urinary tract infections (UTI), lower urinary tract infections (LUTI) and pyelonephritis (Pyelo)

Incidence for daily admissions for renal disease in relation to a 1°C increase in daily temperature (maximum, minimum and average) for admissions for all the renal categories following a lag period of 1--5 days were examined. The results show a lag effect of temperature was associated with all the renal categories and daily temperature (maximum, minimum and average) with the exception of pyelonephritis. This lag effect appeared to last the longest for total renal disease, urolithiasis, renal failure and AKI. Admissions for CKD were associated with a lag effect even if admission were not increased on the day when the daily temperatures were recorded. Similar to the admissions rates without a lag period, IRRs were generally highest when associated with minimum daily temperature followed by average temperature and then maximum temperature. The effect of minimum temperature appeared to be strongest on the day as opposed to following a lag period, with the exception of a very small increase in IRR for CKD for both IP and ED admissions (0.1%). When examining maximum temperature, however, the effect appeared to be strongest 1--3 days after the temperature exposure. The lag period analyses, and accompanying graphs for maximum and minimum temperature, are shown in Appendix [2](#Sec12){ref-type="sec"}.

The effects of gender on the associations between renal admissions and temperature were examined; however, there were less statistically relevant results when looking at genders separately, likely due to reduced power. For male ED presentations, results were statistically significant for total renal disease and urolithiasis. For male inpatient presentations, results were statistically significant for AKI and CKD instead. For ED presentations among females, results were statistically significant for renal failure, AKI, UTIs and LUTIs. The only statistically significant changes in female inpatient presentations were with admissions for urolithiasis. Both genders had increased ED admissions for total renal disease. Males also showed increased ED admissions for urolithiasis and renal failure, whilst females demonstrated increased ED admissions for renal failure, AKI, UTIs and LUTIs. The gender-stratified analyses, including graphs, are available in Appendix [3](#Sec13){ref-type="sec"}.

The effects of age group (\<65 years and ≥65 years) on the associations between renal admissions and temperature were examined. In those aged \<65 years old, there were statistically significant increases in ED admissions for total renal disease, urolithiasis, renal failure, and AKI associated with daily temperature (maximum, minimum and average). For elderly-related admissions, the only statistically significant increase in inpatient admissions was for pyelonephritis. The age-stratified analyses, including graphs, are available in Appendix [4](#Sec14){ref-type="sec"}.

Discussion {#Sec8}
==========

This study investigated the associations between temperature and admissions for a range of specific renal diseases in Adelaide, a city with a temperate climate. No previous Australian study has investigated the link between heat exposure and urolithiasis, UTIs and CKD at a population level. Furthermore it is the only SA study that examines the effect of lag periods and gender on heat exposure with regards to renal disease. The only previous SA study in Adelaide that investigated a direct link between temperature and renal disease, only assessed the relationship above predefined temperature thresholds, and it did not investigate specific renal categories \[[@CR12]\].

This study showed an increased incidence of renal disease, urolithiasis, renal failure (both acute and chronic) and UTIs, specifically lower UTIs, in relation to daily temperature (maximum, minimum and average). Inpatient and ED admissions for total renal disease, renal failure and AKI increased with daily maximum, minimum and average temperatures, and ED admissions for CKD increased with minimum temperature. The results for total renal disease and AKI are consistent with previous studies in Adelaide and Sydney \[[@CR4], [@CR10], [@CR12], [@CR43]\]. An increase was also found in inpatient admissions for UTIs and LUTIs in association with increasing temperature. Older patients are normally more prone to UTIs, and concurrent dehydration stress could predispose them further \[[@CR41]\]. We did not find a significant increase in UTIs in the population aged over 65 years, however this may have been due to a decrease in statistical power because of sample size. ED and inpatient admission rates for urolithiasis increased with higher temperatures. Australian studies have demonstrated seasonal variation in the incidence of renal colic -- highest in summer and autumn \[[@CR27], [@CR28], [@CR45]\], which is consistent with our findings. Admissions for AKI showed the greatest increase in relation to heat exposure with maximum, minimum and average daily temperature. Dehydration has a stronger established link with AKI \[[@CR46]\]. Comparable effects of temperature on renal failure (AKI and CKD collectively) were observed, which were likely due to the increased AKI admissions. On a similar note, as the large majority of total renal disease cases were AKI and urolithiasis, these admissions are likely to explain the increased admissions for total renal disease with heat exposure.

High temperatures are believed to predispose to renal disease due to heat-induced sweating, leading to decreased extracellular fluid (ECF) and subsequent dehydration \[[@CR14]\]. In the case of urolithiasis, low ECF leads to increased secretion of vasopressin. Vasopressin promotes reabsorption of water from renal filtrate causing increased urinary concentration. This increases the concentration of calcium and uric acid, predisposing to supersaturation of these solutes and hence accelerating the rate of stone formation \[[@CR14], [@CR25], [@CR41], [@CR47]\]. Stones can grow over hours in an appropriate urinary environment \[[@CR48]\]. Low ECF, with subsequent decreased blood volume, results in less blood being filtrated by the kidney and hence a decreased glomerular filtration rate. This can lead to AKI \[[@CR46], [@CR49]\]. Studies have shown dehydration is linked to a higher risk of both AKI and CKD \[[@CR45], [@CR50]\]. Whilst there is evidence to suggest a positive association exists between dehydration and CKD, including an Australian study, a precise mechanism has not been established \[[@CR41], [@CR45], [@CR50], [@CR51]\]. A proposed mechanism is that prolonged elevated vasopressin secretion, induced by chronic dehydration, contributes to progressive tubulointerstitial damage, predisposing to CKD \[[@CR41], [@CR52]\]. A USA study showed increased admissions for UTIs during heatwaves \[[@CR3]\]. Chronic low urine output, which can result from decreased urine volume secondary to dehydration, has been linked to a higher risk of UTI \[[@CR41]\]. Hypothesized, but unproven, mechanisms for this observation stem from decreased water within the urine. This leads to increased bacterial concentration (predisposing to infection) and increased urine osmolality with subsequent urine acidity that promotes bacterial adhesion to the urinary epithelium \[[@CR41]\]. Decreased urinary volume can also result in less "flushing out" of bacteria \[[@CR41]\]. These mechanisms for dehydration resulting in renal disease are outlined in Fig. [5](#Fig5){ref-type="fig"}.Fig. 5Proposed mechanisms for heat exposure leading to renal disease. Heat exposure can induce sweating, leading to decreased extracellular fluid (ECF) with subsequent dehydration. This can lead to renal disease by a variety of mechanisms \[[@CR14], [@CR41], [@CR49]\]

CKD was the only renal category in this study that required a lag period in order to indicate a statistically significant increase in admissions. This may reflect the chronic nature of CKD in which the clinical effect of worsening renal function secondary to dehydration does not present immediately but rather predisposes to an admission approximately 1--3 days later.

The effect of increasing temperature on ED admissions for urolithiasis was higher in males than females. This is consistent with the observation that men are more likely to develop calcium and uric stones and that stones can develop quickly following acute heat exposure \[[@CR14], [@CR47], [@CR53]\]. This increased risk is amplified with increasing temperature. \[[@CR14]\]. In contrast, the effect of increasing temperature on ED admissions for UTIs and LUTIs was only apparent in females. This was probably because females are at greater risk of developing UTIs; one study showed they are 50 times more frequent in adult women without accounting for heat exposure \[[@CR41]\].

It is known that infants, children, and particularly the elderly, are more susceptible to heat-related morbidity than other age groups \[[@CR4], [@CR11], [@CR17], [@CR42], [@CR54]--[@CR56]\]. When examining the effect of age in this study, those aged \<65 had statistically significant results for ED admissions for urolithiasis, renal failure and AKI, but not the elderly. This could have reflected the acute nature of dehydration-predisposing activities that those aged \<65 undertake, such as intense exercise or severe occupational heat exposure, whereas the onset of dehydration in the elderly may be more gradual. Alternatively the difference between the results in the two age groups could have resulted from a lack of statistical power. It should be noted that there were less statistically relevant results when stratifying by genders and age. For example, inpatient admissions for UTIs and LUTIs were statistically significant for maximum, minimum and average temperature for both genders combined, but no significance was found when examining the genders individually.

Adverse health effects of extreme heat exposure are largely preventable \[[@CR57]\]. The SA Government is undertaking prevention strategies to reduce morbidity during heat events. These strategies include media announcements raising awareness of heat events and advice to minimize heat-related morbidity \[[@CR58]\]. Such advice includes maintaining adequate hydration, use of air conditioning, keeping out of the sun and cool clothing \[[@CR58]\]. The increased risk of renal disease should also be advertised to the general public as part of these strategies. Certain individuals deemed to be more vulnerable to heat-related morbidity, including the elderly and some mental health clients, are targeted \[[@CR4], [@CR11], [@CR17], [@CR42], [@CR54]--[@CR56], [@CR58]\]. The assessment and monitoring of vulnerable individuals is carried out by community health managers \[[@CR58]\]. These vulnerable individuals are further targeted by these strategies, such as phone calls to these individuals or their carers for additional heat event awareness and advice \[[@CR58]\]. People with a significantly high risk of developing renal disease, as identified by clinicians, should also be included in this vulnerable group of individuals, because renal disease is more likely to occur during heatwaves. For example, in the case of AKI, fluid-restricted individuals or those taking nephrotoxic medications \[[@CR46]\], and in the case of urolithiasis, patients with a past history of urolithiasis \[[@CR28]\]. This is especially important for AKI, as it is associated with increased mortality \[[@CR59]\]. Primary care and renal physicians should inform vulnerable patients of the risks and recommend preventative measures during their consultations, particularly shortly before and throughout the warm season. Furthermore health service providers could tailor these risk-reducing strategies to each individual patient, for example, by recommending a patient to rehydrate at set times during the day with a set volume at each time, and to have extra hydration following prolonged heat exposure such as during work. At a policy level, government and service providers should consider increasing the capacity for renal health care, particularly during the warm season, in preparation for the increase in renal disease frequency.

This study provides the most comprehensive examination of different renal disease categories in relation to heat exposure to date in Australia. Over 80,000 ED admissions and 40,000 inpatient admissions were tested in this study; the large sample size is necessary to provide adequate statistical power when examining subdivided renal categories. Multiple measures of temperature were tested to add reliability to the results and lag periods of up to five days following temperature exposure were assessed. This study also considered differences between genders and age groups.

This study has some limitations, including potential misclassification of heat exposure. Those without access to air conditioning have increased heat exposure, as air conditioners are protective for heat adverse outcomes \[[@CR1], [@CR60]--[@CR63]\]. However, Adelaide has high air-conditioning coverage, therefore its impact should be minimum. This study did not account for humidity and air pollution, in particular ozone and particulate matter, which have been linked to greater heat-related morbidity; but this effect is minimal, and air pollution may not affect renal disease \[[@CR12], [@CR17], [@CR18], [@CR45], [@CR64], [@CR65]\]. All temperature data were acquired from a single meteorological station, and, while this is representative of metropolitan Adelaide, it would have been more accurate to utilize data from multiple climate stations matched to the patients' home addresses. However, other stations reporting meteorological data from metropolitan Adelaide, including Adelaide and Parafield Airports, showed similar temperatures to those of Kent Town \[[@CR37]\]. When examining age, it would have been preferred to assess a number of age groups, such as children. However, the main concerning age, 65 and above (the elderly), was examined \[[@CR4], [@CR11], [@CR17], [@CR42], [@CR55], [@CR56]\]. With ICD-codes, diagnoses can be under-reported or miscoded \[[@CR3], [@CR11], [@CR26]\]. Only up to two secondary diagnoses for inpatient admissions, and none for ED admissions, were included, hence the number of admissions were likely under-reported. Finally, medical complications attributed to heat events may occur at some time even without heat exposure; that is, the exposure would lead to an earlier complication instead of an additional one \[[@CR3], [@CR66], [@CR67]\].

Further research is warranted to analyze individual renal diseases in more detail. To complement population based studies, a clinical audit trial could enable data to be collected from hospital records for targeted renal outcomes during heat events, revealing more comprehensive information regarding clinical, social and behavioral risk factors. These factors could include co-morbidities such as diabetes and heart failure that have been associated with worse outcomes during severe heat exposure \[[@CR54], [@CR68], [@CR69]\]. Certain occupations, such as mining and agriculture, are risk factors due to occupational heat exposure, which is additive to seasonal exposure \[[@CR5], [@CR70]--[@CR73]\]. Psychiatric conditions, impaired mobility, a greater number of co-morbidities, social isolation and low socio-economic status have been linked to adverse heat outcomes \[[@CR16], [@CR18], [@CR19], [@CR30], [@CR62], [@CR73], [@CR74]\]. Medications that can increase susceptibility to heat-related renal disease by impairing thermotolerance, in particular psychotropic drugs, diuretics and β-blockers, should also be evaluated \[[@CR11], [@CR75]--[@CR77]\]. The SA Extreme Heat Arrangements Plan, a SA government initiative which implements heat warning and targeted interventions during periods of extreme heat, has been shown to lower the rates of morbidity outcomes associated of renal disease \[[@CR78]\]. This plan could be further evaluated by investigating its effectiveness on specific renal diseases.

Conclusions {#Sec9}
===========

An increased risk of specific renal categories was observed with increasing temperatures. This was most evident with AKI but was also observed with urolithiasis and UTIs, the latter especially with females. The results have implications for ongoing public health interventions aimed at preventing heat-related morbidity, by targeting individuals at greater risk of developing renal disease, including specific renal diseases, and improving community awareness of the risks with regards to heat and renal disease in Adelaide.
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Additional file 1:Daily temperature data (maximum and minimum) from the Bureau of Meteorlogy from a monitoring station in Kent Town (station 023090), Adelaide. The data extends from July 2003 to March 2014. (XLS 556 kb)
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Fig. 6Incidence rate ratios (IRRs) for renal outcomes and daily maximum temperature for lag periods of 0--5 days. Graphs for incidence rate ratios (IRRs) for daily admissions for renal diseases and associated 95% confidence intervals (95% CI) in relation to daily maximum temperature per 1°C, during the warm season (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Admissions are listed for each day over a lag period of 0 to 5 days. The left sides of the graphs represent emergency department admissions, and the right sides represent inpatient admissions. Graphs are in relation to (**a**); total renal disease (**b**); urolithiasis (**c**); renal failure (**d**); acute kidney injury (**e**); chronic kidney disease (**f**); urinary tract infections (**g**); lower urinary tract infections (**h**); pyelonephritis

Table 4Poisson goodness-of-fit testsDiseaseStatistical testDaily maximum temperature (1980 df)EDInpatientTotal renal diseaseDeviance goodness-of-fit statistic2216.9462271.521*P*-value\<0.001\<0.001Pearson goodness-of-fit statistic2199.8262244.133*P*-value\<0.001\<0.001UrolithiasisDeviance goodness-of-fit statistic2290.7032325.260*P*-value\<0.001\<0.001Pearson goodness-of-fit statistic2150.7422071.219*P*-value0.0040.075Renal failureDeviance goodness-of-fit statistic2470.9102387.224*P*-value\<0.001\<0.001Pearson goodness-of-fit statistic2241.7992133.986*P*-value\<0.0010.008AKIDeviance goodness-of-fit statistic2438.8742407.545*P*-value\<0.001\<0.001Pearson goodness-of-fit statistic2294.1012171.447*P*-value\<0.0010.002CKDDeviance goodness-of-fit statistic1934.4982279.640*P*-value0.764\<0.001Pearson goodness-of-fit statistic1906.8822069.318*P*-value0.8780.079UTIDeviance goodness-of-fit statistic2121.8262131.721*P*-value0.0140.009Pearson goodness-of-fit statistic2102.8392079.242*P*-value0.0270.059Lower UTIDeviance goodness-of-fit statistic2108.5042168.087*P*-value0.0220.002Pearson goodness-of-fit statistic2083.3432103.063*P*-value0.0520.027PyelonephritisDeviance goodness-of-fit statistic2456.3062257.211*P*-value\<0.001\<0.001Pearson goodness-of-fit statistic2159.4921949.885*P*-value0.0030.681Poisson regression was used to estimate incidence rate ratios (IRRs) for daily emergency department (ED) and inpatient admissions for renal diseases in relation to an increase in daily maximum temperature per 1°C during the warm season (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Deviance and Pearson goodness-of-fit tests were then applied to assess whether a Poisson model fits the dataThe deviance and Pearson goodness-of-fit test show how well a Poisson model fits the data. Each test yields a test statistic, comparing the observed count to the expected count under a Poisson model. The test statistics and degrees of freedom (df) are used to generate P-values. A *P*-value of \<0.05 indicates a poor fit of the Poisson model -- most of the results indicated a poor fit
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Fig. 7Incidence rate ratios (IRRs) for renal outcomes and daily minimum temperature for lag periods of 0--5 days. Graphs for incidence rate ratios (IRRs) for daily admissions for renal diseases and associated 95% confidence intervals (95% CI) in relation to daily minimum temperature per 1°C, during the warm season (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Admissions are listed for each day over a lag period of 0 to 5 days. The left sides of the graphs represent emergency department admissions, and the right sides represent inpatient admissions. Graphs are in relation to (**a**); total renal disease (**b**); urolithiasis (**c**); renal failure (**d**); acute kidney injury (**e**); chronic kidney disease (**f**); urinary tract infections (**g**); lower urinary tract infections (**h**); pyelonephritis

Table 5Incidence rate ratios (IRRs) for renal outcomes and daily temperature for lag periods (0--5 days)TemperatureAdmission dataDiseaseLag periodIRR95% CI*P*-valueMaximumEDTotal renal0 days1.0041.002--1.005\<0.001disease[1 day1.006]{.ul}1.004--1.008\<0.0012 days1.0061.004--1.008\<0.0013 days1.0051.003--1.007\<0.0014 days1.0041.002--1.005\<0.0015 days1.0031.001--1.0050.001Urolithiasis0 days1.0061.003--1.010\<0.0011 day1.0111.007--1.014\<0.001[2 days1.011]{.ul}1.008--1.015\<0.0013 days1.0101.006--1.013\<0.0014 days1.0061.003--1.010\<0.0015 days1.0041.001--1.0080.012Renal failure0 days1.0181.012--1.024\<0.001[1 day1.024]{.ul}1.018--1.030\<0.0012 days1.0181.011--1.024\<0.0013 days1.0111.005--1.0170.0014 days1.0081.002--1.0140.0125 days1.0071.001--1.0130.024AKI0 days1.0231.016--1.031\<0.001[1 day1.031]{.ul}1.023--1.039\<0.0012 days1.0231.015--1.030\<0.0013 days1.0141.006--1.022\<0.0014 days1.0121.004--1.0200.0025 days1.0081.000--1.0160.047CKD0 days1.0050.994--1.0160.365[1 day1.012]{.ul}1.001--1.0240.032 days1.0100.999--1.0210.0853 days1.0060.995--1.0180.2634 days1.0010.990--1.0130.8025 days1.0040.993--1.0160.447UTI0 days1.0010.999--1.0030.4111 day1.0021.000--1.0040.0422 days1.0021.000--1.0040.043[3 days1.003]{.ul}1.000--1.0050.024 days1.0021.000--1.0040.1145 days1.0021.000--1.0040.08Lower UTI0 days1.0010.999--1.0030.5071 day1.0021.000--1.0040.0782 days1.0021.000--1.0040.094[3 days1.003]{.ul}1.000--1.0050.0184 days1.0021.000--1.0040.0815 days1.0021.000--1.0040.086Pyelonephritis0 days1.0020.995--1.0090.5471 day1.0040.997--1.0100.2722 days1.0050.998--1.0110.1843 days1.0010.994--1.0080.7614 days0.9990.993--1.0060.8685 days1.0010.995--1.0080.682InpatientTotal renal0 days1.0061.004--1.009\<0.001disease[1 day1.007]{.ul}1.005--1.010\<0.0012 days1.0071.004--1.009\<0.0013 days1.0061.004--1.009\<0.0014 days1.0031.000--1.0050.0355 days0.9990.997--1.0020.562Urolithiasis0 days1.0071.002--1.0120.0091 day1.0101.005--1.015\<0.001[2 days1.011]{.ul}1.006--1.016\<0.0013 days1.0101.005--1.015\<0.0014 days1.0061.000--1.0110.045 days0.9990.993--1.0040.631Renal failure[0 days1.016]{.ul}1.010--1.022\<0.0011 day1.0161.010--1.022\<0.0012 days1.0151.009--1.021\<0.0013 days1.0141.008--1.020\<0.0014 days1.0071.001--1.0130.0155 days1.0000.994--1.0060.993AKI0 days1.0201.013--1.026\<0.001[1 day1.021]{.ul}1.014--1.027\<0.0012 days1.0181.011--1.025\<0.0013 days1.0141.007--1.020\<0.0014 days1.0071.001--1.0140.0345 days1.0000.994--1.0070.955CKD0 days1.0060.997--1.0140.1711 day1.0050.997--1.0140.2082 days1.0091.000--1.0180.042[3 days1.010]{.ul}1.001--1.0180.0234 days1.0030.995--1.0120.4495 days0.9960.987--1.0040.317UTI0 days1.0041.001--1.0080.005[1 day1.005]{.ul}1.001--1.0080.0042 days1.0041.000--1.0070.0273 days1.0031.000--1.0060.0444 days1.0000.997--1.0030.9085 days0.9990.996--1.0020.548Lower UTI0 days1.0051.002--1.0090.002[1 day1.005]{.ul}1.002--1.0090.0022 days1.0041.000--1.0070.0283 days1.0031.000--1.0070.0554 days1.0000.997--1.0040.8665 days0.9990.996--1.0030.608Pyelonephritis0 days1.0020.996--1.0090.4721 day1.0030.996--1.0090.472 days1.0040.997--1.0100.3143 days1.0040.997--1.0100.3074 days0.9990.993--1.0060.8645 days0.9970.990--1.0040.386MinimumEDTotal renal[0 days1.009]{.ul}1.006--1.011\<0.001disease1 day1.0081.005--1.010\<0.0012 days1.0071.005--1.010\<0.0013 days1.0051.003--1.008\<0.0014 days1.0041.002--1.0070.0015 days1.0021.000--1.0050.082Urolithiasis0 days1.0151.010--1.020\<0.001[1 day1.015]{.ul}1.010--1.020\<0.0012 days1.0141.009--1.019\<0.0013 days1.0091.004--1.014\<0.0014 days1.0061.001--1.0110.0225 days1.0030.998--1.0080.196Renal failure[0 days1.030]{.ul}1.022--1.039\<0.0011 day1.0271.019--1.036\<0.0012 days1.0181.009--1.026\<0.0013 days1.0131.005--1.0220.0024 days1.0121.003--1.0210.0065 days1.0091.001--1.0180.036AKI[0 days1.037]{.ul}1.026--1.048\<0.0011 day1.0351.025--1.046\<0.0012 days1.0211.010--1.032\<0.0013 days1.0171.006--1.0270.0034 days1.0161.005--1.0270.0055 days1.0121.001--1.0230.029CKD0 days1.0171.001--1.0330.036[1 day1.018]{.ul}1.002--1.0340.0242 days1.0171.002--1.0330.0313 days1.0080.992--1.0240.3384 days1.0020.986--1.0180.835 days1.0000.984--1.0160.98UTI[0 days1.004]{.ul}1.000--1.0070.0231 day1.0020.999--1.0050.1162 days1.0031.000--1.0060.063 days1.0020.999--1.0050.1384 days1.0031.000--1.0060.0825 days1.0010.998--1.0040.562Lower UTI[0 days1.003]{.ul}1.000--1.0060.0451 day1.0020.999--1.0050.2162 days1.0031.000--1.0060.0873 days1.0020.999--1.0060.1424 days1.0020.999--1.0060.1535 days1.0010.997--1.0040.706Pyelonephritis0 days1.0060.996--1.0150.2451 day1.0060.996--1.0150.2322 days1.0040.995--1.0130.413 days1.0020.992--1.0110.7524 days1.0060.996--1.0150.2445 days1.0030.994--1.0130.495InpatientTotal renal[0 days1.012]{.ul}1.008--1.015\<0.001disease1 day1.0101.007--1.014\<0.0012 days1.0081.004--1.011\<0.0013 days1.0041.001--1.0080.0184 days1.0000.997--1.0040.9875 days1.0000.996--1.0030.942Urolithiasis[0 days1.014]{.ul}1.007--1.022\<0.0011 day1.0121.004--1.0190.0022 days1.0071.000--1.0150.0623 days1.0060.998--1.0130.1474 days0.9970.990--1.0050.5145 days0.9970.989--1.0040.39Renal failure[0 days1.024]{.ul}1.015--1.032\<0.0011 day1.0201.012--1.029\<0.0012 days1.0161.008--1.025\<0.0013 days1.0101.002--1.0190.0164 days1.0030.995--1.0120.4315 days1.0020.993--1.0100.695AKI[0 days1.028]{.ul}1.019--1.038\<0.0011 day1.0251.015--1.034\<0.0012 days1.0181.008--1.027\<0.0013 days1.0080.999--1.0180.0824 days1.0030.994--1.0130.5135 days1.0030.994--1.0130.521CKD0 days1.0110.999--1.0230.0681 day1.0121.000--1.0240.0592 days1.0100.998--1.0220.0893 days1.0060.994--1.0180.3614 days0.9990.987--1.0110.8845 days0.9990.987--1.0110.859UTI[0 days1.008]{.ul}1.003--1.012\<0.0011 day1.0061.002--1.0110.0072 days1.0041.000--1.0090.0543 days1.0010.997--1.0060.6334 days0.9990.995--1.0040.6985 days1.0000.995--1.0040.903Lower UTI[0 days1.009]{.ul}1.004--1.014\<0.0011 day1.0061.001--1.0110.0172 days1.0040.999--1.0090.1263 days1.0010.996--1.0060.6774 days0.9990.994--1.0040.6245 days1.0000.995--1.0050.986Pyelonephritis0 days1.0050.995--1.0140.3461 day1.0080.998--1.0180.112 days1.0080.998--1.0170.1143 days1.0000.990--1.0100.9864 days0.9980.988--1.0070.625 days0.9990.989--1.0090.833AverageEDTotal renal0 days1.0071.004--1.009\<0.001disease[1 day1.009]{.ul}1.006--1.011\<0.0012 days1.0081.006--1.010\<0.0013 days1.0071.004--1.009\<0.0014 days1.0051.003--1.007\<0.0015 days1.0041.001--1.0060.002Urolithiasis0 days1.0121.007--1.016\<0.0011 day1.0151.011--1.020\<0.001[2 days1.016]{.ul}1.011--1.020\<0.0013 days1.0121.007--1.016\<0.0014 days1.0081.003--1.0120.0015 days1.0051.001--1.0100.024Renal failure0 days1.0281.020--1.036\<0.001[1 day1.032]{.ul}1.024--1.040\<0.0012 days1.0221.014--1.030\<0.0013 days1.0141.007--1.022\<0.0014 days1.0121.004--1.0200.0045 days1.0101.002--1.0180.015AKI0 days1.0351.025--1.045\<0.001[1 day1.041]{.ul}1.031--1.051\<0.0012 days1.0281.018--1.038\<0.0013 days1.0191.009--1.029\<0.0014 days1.0171.007--1.0270.0015 days1.0121.002--1.0220.021CKD0 days1.0110.997--1.0260.125[1 day1.018]{.ul}1.004--1.0330.0142 days1.0161.001--1.0300.0343 days1.0090.994--1.0230.2484 days1.0020.987--1.0170.7845 days1.0040.989--1.0180.621UTI0 days1.0020.999--1.0050.1211 day1.0031.000--1.0060.0412 days1.0031.000--1.0060.03[3 days1.003]{.ul}1.000--1.0060.0284 days1.0031.000--1.0050.0635 days1.0020.999--1.0050.165Lower UTI0 days1.0020.999--1.0050.1841 day1.0031.000--1.0060.0852 days1.0031.000--1.0060.063[3 days1.003]{.ul}1.000--1.0060.0264 days1.0031.000--1.0060.0685 days1.0020.999--1.0050.203Pyelonephritis0 days1.0040.995--1.0130.3641 day1.0060.997--1.0140.2072 days1.0050.997--1.0140.2153 days1.0020.993--1.0100.7324 days1.0020.993--1.0110.675 days1.0030.994--1.0110.564InpatientTotal renal0 days1.0101.007--1.013\<0.001disease[1 day1.011]{.ul}1.007--1.014\<0.0012 days1.0091.006--1.012\<0.0013 days1.0071.004--1.010\<0.0014 days1.0020.999--1.0050.1715 days0.9990.996--1.0030.689Urolithiasis0 days1.0121.005--1.0190.001[1 day1.013]{.ul}1.007--1.020\<0.0012 days1.0121.005--1.019\<0.0013 days1.0111.004--1.0180.0024 days1.0040.997--1.0110.2975 days0.9980.991--1.0040.483Renal failure[0 days1.023]{.ul}1.016--1.031\<0.0011 day1.0221.014--1.029\<0.0012 days1.0191.012--1.027\<0.0013 days1.0161.008--1.024\<0.0014 days1.0081.000--1.0150.0535 days1.0010.993--1.0080.864AKI[0 days1.029]{.ul}1.020--1.037\<0.0011 day1.0281.019--1.036\<0.0012 days1.0221.014--1.031\<0.0013 days1.0151.006--1.0240.0014 days1.0070.999--1.0160.0965 days1.0010.993--1.0100.751CKD0 days1.0100.999--1.0210.0871 day1.0100.998--1.0210.092[2 days1.012]{.ul}1.001--1.0230.0373 days1.0111.000--1.0220.0584 days1.0020.991--1.0140.6795 days0.9960.985--1.0070.466UTI[0 days1.007]{.ul}1.003--1.0110.0011 day1.0061.002--1.0100.0022 days1.0051.001--1.0090.023 days1.0030.999--1.0070.1294 days1.0000.996--1.0040.9065 days0.9990.995--1.0030.663Lower UTI[0 days1.008]{.ul}1.004--1.013\<0.0011 day1.0071.003--1.0120.0022 days1.0051.000--1.0090.0333 days1.0030.999--1.0080.1544 days1.0000.995--1.0040.9015 days0.9990.995--1.0040.735Pyelonephritis0 days1.0040.995--1.0130.3781 day1.0050.997--1.0140.2292 days1.0060.997--1.0150.1683 days1.0030.994--1.0120.5014 days0.9980.990--1.0070.7245 days0.9970.988--1.0060.526Estimated incidence rate ratios (IRRs) and associated 95% confidence intervals and *P*-values for daily admissions for renal diseases in relation to an increase in daily maximum temperature per 1°C over lag 0--5 days during the warm seasons (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Both emergency department (ED) and inpatient admissions were included. The associated lag periods with the highest IRR value (rounded to 3 decimal figures) and are statistically significant are underlined
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Fig. 8Incidence rate ratios (IRRs) for renal admissions and daily temperature stratified by gender. Graphs for incidence rate ratios (IRRs) for daily admissions for renal diseases and associated 95% confidence intervals (95% CI) in relation to daily temperature per 1°C, during the warm season (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Results are shown for females (F) and males (M) separately. Graphs (**a**), (**c**) and (**e**) represent emergency department (ED) admissions, and graphs (**b**), (**d**) and (**f**) represent inpatient admissions. The temperature measures shown are maximum ((**a**) and (**b**)), minimum ((**c**) and (**d**)) and average ((**e**) and (**f**)). The renal categories are: total renal disease (Total); urolithiasis (Uro); renal failure (RF); acute kidney injury (AKI); chronic kidney disease (CKD); urinary tract infections (UTI); lower urinary tract infections (LUTI); pyelonephritis (Pyelo)

Table 6Incidence rate ratios (IRRs) for renal outcomes and daily temperature stratified by genderTemperatureAdmission dataDiseaseGenderIRR95% CI*P*-valueMaximumEDTotal renal diseaseF1.0010.999--1.0030.231M1.0041.001--1.0070.003UrolithiasisF1.0010.994--1.0080.788M1.0051.001--1.0090.026Renal failureF1.0181.009--1.027\<0.001M1.0060.999--1.0140.109AKIF1.0261.014--1.037\<0.001M1.0050.995--1.0150.305CKDF0.9990.982--1.0160.902M1.0010.986--1.0160.873UTIF1.0000.998--1.0030.733M1.0030.999--1.0070.169Lower UTIF1.0000.998--1.0030.863M1.0030.998--1.0070.237PyelonephritisF1.0020.995--1.0090.619M1.0090.9921.0260.319MinimumEDTotal renal diseaseF1.0051.002--1.0080.002M1.0041.000--1.0080.036UrolithiasisF1.0010.991--1.0100.912M1.0030.997--1.0090.327Renal failureF1.0231.010--1.036\<0.001M1.0131.002--1.0250.017AKIF1.0351.019--1.051\<0.001M1.0130.999--1.0280.069CKDF1.0000.976--1.0240.974M1.0070.985--1.0280.542UTIF1.0041.001--1.0070.022M1.0040.998--1.0100.199Lower UTIF1.0041.000--1.0080.029M1.0040.997--1.0100.262PyelonephritisF1.0040.9941.0140.481M1.0110.987--1.0360.383AverageEDTotal renal diseaseF1.0031.000--1.0060.032M1.0051.002--1.0090.004UrolithiasisF1.0010.992--1.0100.834M1.0051.000--1.0100.057Renal failureF1.0251.013--1.037\<0.001M1.0111.001--1.0210.034AKIF1.0361.022--1.051\<0.001M1.0100.997--1.0230.138CKDF0.9990.977--1.0210.913M1.0040.984--1.0230.708UTIF1.0020.999--1.0050.218M1.0040.999--1.0100.143Lower UTIF1.0020.998--1.0050.282M1.0040.998--1.0100.205PyelonephritisF1.0030.994--1.0120.529M1.0120.990--1.0350.297MaximumInpatientTotal renal diseaseF1.0000.996--1.0030.778M1.0010.999--1.0030.231UrolithiasisF0.9920.983--1.0020.139M1.0010.994--1.0080.788Renal failureF1.0040.995--1.0130.347M1.0181.009--1.027\<0.001AKIF1.0050.995--1.0140.361M1.0261.014--1.037\<0.001CKDF1.0070.994--1.0200.289M0.9990.982--1.0160.902UTIF0.9990.996--1.0030.710M1.0000.998--1.0030.733Lower UTIF0.9980.994--1.0020.420M1.0000.998--1.0030.863PyelonephritisF1.0030.996--1.0110.400M0.9940.978--1.0100.470MinimumInpatientTotal renal diseaseF0.9970.992--1.0020.190M0.9970.992--1.0020.256UrolithiasisF0.9830.969--0.9970.021M0.9930.985--1.0020.135Renal failureF1.0000.987--1.0120.946M1.0000.989--1.0120.958AKIF0.9980.984--1.0120.750M0.9990.986--1.0120.852CKDF1.0060.987--1.0240.556M0.9990.983--1.0150.860UTIF0.9980.992--1.0030.415M0.9950.987--1.0020.183Lower UTIF0.9980.992--1.0040.494M0.9970.989--1.0050.437PyelonephritisF0.9960.985--1.0060.419M0.9820.959--1.0060.133AverageInpatientTotal renal diseaseF0.9980.994--1.0030.429M0.9970.993--1.0020.218UrolithiasisF0.9870.974--1.0000.045M0.9920.984--1.0000.047Renal failureF1.0030.992--1.0150.567M0.9980.988--1.0080.706AKIF1.0030.990--1.0160.658M0.9970.985--1.0090.592CKDF1.0080.991--1.0250.341M0.9950.981--1.0100.505UTIF0.9980.994--1.0030.533M0.9960.989--1.0030.271Lower UTIF0.9980.992--1.0030.400M0.9970.990--1.0050.458PyelonephritisF1.0010.991--1.0110.855M0.9870.966--1.0090.243Estimated incidence rate ratios (IRRs) and associated 95% confidence intervals and *P*-values for daily admissions for renal diseases for males and females separately in relation to an increase in daily maximum temperature per 1°C during the warm seasons (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Both emergency department (ED) and inpatient admissions were included

Appendix 4 {#Sec14}
==========

Fig. 9Incidence rate ratios (IRRs) for renal admissions and daily temperature stratified by age (\<65 and 65+ years). Graphs for incidence rate ratios (IRRs) for daily admissions for renal diseases and associated 95% confidence intervals (95% CI) in relation to daily temperature, per 1°C, during the warm season (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Results are shown for those \<65 (\<65) and ≥65 (65+) years. Graphs (**a**), (**c**) and (**e**) represent emergency department (ED) admissions, and graphs (**b**), (**d**) and (**f**) represent inpatient admissions. The temperature measures shown are maximum ((**a**) and (**b**)), minimum ((**c**) and (**d**)) and average ((**e**) and (**f**)). The renal categories are: total renal disease (Total); urolithiasis (Uro); renal failure (RF); acute kidney injury (AKI); chronic kidney disease (CKD); urinary tract infections (UTI); lower urinary tract infections (LUTI); pyelonephritis (Pyelo)

Table 7Incidence rate ratios (IRRs) for renal outcomes and daily temperature stratified by age (\<65 and 65+ years)TemperatureAdmission dataDiseaseAgeIRR95% CI*P*-valueMaximumEDTotal renal disease\<651.0020.999--1.0040.13765+1.0020.999--1.0050.127Urolithiasis\<651.0081.004--1.012\<0.00165+1.0020.994--1.0100.650Renal failure\<651.0131.002--1.0240.02365+1.0050.998--1.0120.143AKI\<651.0271.012--1.0420.00065+1.0050.996--1.0140.287CKD\<650.9960.978--1.0150.66065+1.0070.993--1.0210.336UTI\<650.9980.995--1.0000.06765+1.0020.999--1.0060.245Lower UTI\<650.9970.994--1.0000.02565+1.0020.999--1.0060.243Pyelonephritis\<651.0020.995--1.0100.51065+1.0010.984--1.0180.937MinimumEDTotal renal disease\<651.0071.004--1.010\<0.00165+1.0020.998--1.0060.268Urolithiasis\<651.0171.012--1.022\<0.00165+1.0030.992--1.0150.581Renal failure\<651.0221.007--1.0380.00565+1.0100.999--1.0200.064AKI\<651.0391.019--1.061\<0.00165+1.0030.990--1.0150.658CKD\<651.0020.977--1.0290.85265+1.0170.998--1.0380.084UTI\<651.0000.997--1.0040.90565+1.0010.996--1.0060.792Lower UTI\<650.9990.995--1.0030.62965+1.0000.995--1.0050.968Pyelonephritis\<651.0070.997--1.0180.15265+1.0140.989--1.0390.274AverageEDTotal renal disease\<651.0041.001--1.0070.00365+1.0030.999--1.0070.131Urolithiasis\<651.0141.009--1.019\<0.00165+1.0030.993--1.0140.555Renal failure\<651.0201.006--1.0340.00665+1.0080.999--1.0180.076AKI\<651.0391.020--1.059\<0.00165+1.0050.994--1.0170.379CKD\<650.9970.974--1.0220.83165+1.0130.995--1.0310.160UTI\<650.9980.995--1.0010.24665+1.0020.998--1.0070.377Lower UTI\<650.9970.993--1.0000.08965+1.0020.997--1.0070.431Pyelonephritis\<651.0050.996--1.0140.28565+1.0060.984--1.0290.587MaximumInpatientTotal renal disease\<651.0010.998--1.0040.58765+1.0020.999--1.0050.229Urolithiasis\<651.0030.997--1.0090.33465+1.0020.991--1.0130.754Renal failure\<651.0020.992--1.0130.65765+0.9970.990--1.0040.388AKI\<651.0060.993--1.0190.38965+0.9970.990--1.0050.479CKD\<651.0010.986--1.0170.88165+0.9960.986--1.0060.419UTI\<651.0000.996--1.0050.88765+1.0030.999--1.0070.185Lower UTI\<650.9990.994--1.0040.69365+1.0020.998--1.0060.282Pyelonephritis\<651.0020.995--1.0100.54065+1.0130.997--1.0300.115MinimumInpatientTotal renal disease\<651.0000.996--1.0050.89665+1.0020.998--1.0070.309Urolithiasis\<651.0010.993--1.0090.78265+1.0010.985--1.0170.912Renal failure\<651.0000.985--1.0150.99565+0.9970.987--1.0070.563AKI\<651.0060.987--1.0250.54065+0.9980.988--1.0090.780CKD\<650.9910.969--1.0130.40665+0.9950.981--1.0100.516UTI\<651.0020.996--1.0090.48965+1.0020.996--1.0080.499Lower UTI\<650.9990.991--1.0060.74965+1.0010.995--1.0070.812Pyelonephritis\<651.0090.999--1.0200.08065+1.0241.001--1.0480.042AverageInpatientTotal renal disease\<651.0010.997--1.0050.66765+1.0030.998--1.0070.222Urolithiasis\<651.0030.996--1.0100.43965+1.0020.987--1.0170.805Renal failure\<651.0020.988--1.0160.76265+0.9960.987--1.0050.404AKI\<651.0070.991--1.0250.39065+0.9970.987--1.0070.554CKD\<650.9970.977--1.0170.77265+0.9940.981--1.0080.399UTI\<651.0010.995--1.0070.67565+1.0030.998--1.0080.249Lower UTI\<650.9990.992--1.0060.69565+1.0020.997--1.0080.429Pyelonephritis\<651.0060.996--1.0150.23165+1.0211.000--1.0430.051Estimated incidence rate ratios (IRRs) and associated 95% confidence intervals and *P*-values for daily admissions for renal diseases in relation to an increase in daily maximum temperature per 1°C during the warm seasons (October -- March) in Adelaide from 1 July 2003 to 31 March 2014. Patients are separated into two groups: one for patients aged \<65 years old, another for patients aged ≥65 years old. Both emergency department (ED) and inpatient admissions were included

AKI

:   Acute kidney injury

CKD

:   Chronic kidney disease

ECF

:   Extracellular fluid

ED

:   Emergency department

ICD-10

:   International Classification of Diseases, 10th revision

IRR

:   Incidence rate ratio

LUTIs

:   Lower urinary tract infections

NB

:   Negative binomial

SA

:   South Australian

USA

:   United States of America

UTIs

:   Urinary tract infections
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